CLEC1B/CLEC-2 Protein, Human (HEK293, His, solution)

CLEC1B/CLEC-2 protein is a C-type lectin-like receptor that acts as a platelet receptor and snake venom protein receptor for PDPN in microbial infections. Upon activation, it initiates a signaling cascade involving SRC and SYK kinases, leading to PLCG2 activation. CLEC1B/CLEC-2 Protein, Human (HEK293, His, solution) is the recombinant human-derived CLEC1B/CLEC-2 protein, expressed by HEK293 , with N-His labeled tag.

CLEC1B/CLEC-2 protein serves as a C-type lectin-like receptor with a notable function as a platelet receptor for the lymphatic endothelial marker, PDPN. Upon ligand activation, it initiates signaling cascades involving the sequential activation of SRC and SYK tyrosine kinases, ultimately leading to the activation of PLCG2. In the context of microbial infection, CLEC1B/CLEC-2 acts as a receptor for the platelet-aggregating snake venom protein rhodocytin. Rhodocytin binding induces tyrosine phosphorylation, facilitating the binding of spleen tyrosine kinase (SYK) and initiating downstream tyrosine phosphorylation events, along with the activation of PLCG2. This multifaceted role highlights the involvement of CLEC1B/CLEC-2 in platelet function and immune responses, particularly in the context of interactions with PDPN and rhodocytin.

Human

HEK293

N-His

Q9P126-1 (Q58-P229)

51266  [NCBI]

Extracellular Domain

QRNYLQGENENRTGTLQQLAKRFCQYVVKQSELKGTFKGHKCSPCDTNWRYYGDSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTHLIRWVGLSRQKSNEVWKWEDGSVISENMFEFLEDGKGNMNCAYFHNGKMHPTFCENKHYLMCERKAGMTKVDQLP

35-38 kDa

≥ 80%, as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.